Cornerstone Wealth Management, LLC Pfizer Inc Transaction History

Cornerstone Wealth Management, LLC

$1.39 Billion
Q3 2024

A detailed history of Cornerstone Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cornerstone Wealth Management, LLC holds 77,912 shares of PFE stock, worth $2.08 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

77,912

Previous 72,058 8.12%

Holding current value

$2.08 Million

Previous $2.02 Million 11.81%

% of portfolio

0.16%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $162,155 - $183,757	5,854 Added 8.12%	77,912 $2.25 Million
Q2 2024 Jul 16, 2024	BUY	$25.26 - $29.6 $215,038 - $251,984	8,513 Added 13.4%	72,058 $2.02 Million
Q1 2024 Apr 19, 2024	BUY	$25.89 - $29.73 $267,029 - $306,635	10,314 Added 19.38%	63,545 $1.76 Million
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $328,114 - $426,184	-12,557 Reduced 19.09%	53,231 $1.53 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $41,620 - $48,650	1,297 Added 2.01%	65,788 $2.18 Million
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $93,225 - $107,859	-2,581 Reduced 3.85%	64,491 $2.37 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $346,474 - $451,058	8,796 Added 15.09%	67,072 $2.74 Million
Q3 2022 Oct 14, 2022	BUY	$43.76 - $53.42 $8,576 - $10,470	196 Added 0.34%	58,276 $2.55 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $160,063 - $189,784	3,440 Added 6.3%	58,080 $3.05 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $19,855 - $24,603	434 Added 0.8%	54,640 $2.83 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $80,532 - $119,376	1,949 Added 3.73%	54,206 $3.22 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $75,674 - $97,209	1,928 Added 3.83%	52,257 $2.25 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $24,346 - $27,581	-678 Reduced 1.33%	50,329 $1.97 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $168,119 - $189,605	-5,020 Reduced 8.96%	51,007 $1.85 Million
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $181,273 - $230,504	5,416 Added 10.7%	56,027 $2.06 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $207,581 - $243,540	6,538 Added 14.83%	50,611 $1.86 Million
Q2 2020 Jul 16, 2020	BUY	$30.12 - $36.54 $210,267 - $255,085	6,981 Added 18.82%	44,073 $1.44 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $112,228 - $160,350	4,152 Added 12.6%	37,092 $1.21 Million
Q4 2019 Feb 20, 2020	SELL	$32.92 - $37.36 $66,103 - $75,018	-2,008 Reduced 5.75%	32,940 $1.29 Million
Q3 2019 Oct 29, 2019	SELL	$32.49 - $42.13 $41,457 - $53,757	-1,276 Reduced 3.52%	34,948 $1.26 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $139,710 - $156,862	-3,778 Reduced 9.44%	36,224 $1.56 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $273,337 - $300,306	7,289 Added 22.28%	40,002 $2.88 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $52.1 Million - $59.4 Million	-1,355,146 Reduced 97.64%	32,713 $1.43 Million
Q3 2018 Oct 19, 2018	BUY	$34.47 - $41.81 $3.68 Million - $4.47 Million	106,868 Added 8.34%	1,387,859 $38.4 Million
Q2 2018 Jul 20, 2018	BUY	$32.98 - $35.16 $41 Million - $43.7 Million	1,242,876 Added 3260.86%	1,280,991 $35.3 Million
Q1 2018 Apr 24, 2018	BUY	$31.91 - $37.02 $55,651 - $64,562	1,744 Added 4.8%	38,115 $1.35 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $67,517 - $71,638	-2,030 Reduced 5.29%	36,371 $1.32 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $125,953 - $138,751	4,063 Added 11.83%	38,401 $1.39 Million
Q2 2017 Aug 11, 2017	BUY	N/A	34,338	34,338 $1.15 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.

Account

Cornerstone Wealth Management, LLC Pfizer Inc Transaction History